Literature DB >> 14615878

US and UK policies governing research with humans.

Karen J Maschke1.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Legal Approach

Mesh：

Year:  2003        PMID： 14615878     DOI： 10.1007/s00213-003-1666-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  21 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  The new system of review by multicentre research ethics committees: prospective study.

Authors:  J Tully; N Ninis; R Booy; R Viner
Journal:  BMJ       Date:  2000-04-29

3.  Pediatric research regulations under legal scrutiny: Grimes narrows their interpretation.

Authors:  Loretta M Kopelman
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

4.  Ethics behind closed doors: do research ethics committees need secrecy?

Authors:  R Ashcroft; N Pfeffer
Journal:  BMJ       Date:  2001-05-26

Review 5.  Defining and describing benefit appropriately in clinical trials.

Authors:  N M King
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

6.  Adverse events reporting--the tip of an iceberg.

Authors:  A E Shamoo
Journal:  Account Res       Date:  2001       Impact factor: 2.622

7.  In loco parentis. Minimal risk as an ethical threshold for research upon children.

Authors:  B Freedman; A Fuks; C Weijer
Journal:  Hastings Cent Rep       Date:  1993 Mar-Apr       Impact factor: 2.683

8.  Assent observed: children's involvement in leukemia treatment and research discussions.

Authors:  Joseph Quinn Olechnowicz; Michelle Eder; Christian Simon; Stephen Zyzanski; Eric Kodish
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

Review 9.  Informed consent in emergency research. Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers.

Authors:  M H Biros; R J Lewis; C M Olson; J W Runge; R O Cummins; N Fost
Journal:  JAMA       Date:  1995-04-26       Impact factor: 56.272

10.  Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members.

Authors:  H E M Van Luijn; A W Musschenga; R B Keus; W M Robinson; N K Aaronson
Journal:  Ann Oncol       Date:  2002-08       Impact factor: 32.976
View more
  1 in total

1.  Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.

Authors:  James D Neaton; Abdel Babiker; Mark Bohnhorst; Janet Darbyshire; Eileen Denning; Arnie Frishman; Jesper Grarup; Gregg Larson; Jens Lundgren
Journal:  Clin Trials       Date:  2010-08-20       Impact factor: 2.486
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.